Nephrocare Health Services Limited (NSE:NEPHROPLUS)
India · Delayed Price · Currency is INR 628.80
-6.90 (-1.09%)
At close: Jul 20, 2026
NSE:NEPHROPLUS Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, NSE:NEPHROPLUS stock has a consensus rating of "Buy" and an average price target of ₹771.25. The average 1-year stock price forecast is 22.65% higher than the current stock price, while the lowest is ₹660.00 (+4.96%) and the highest is ₹1,000 (+59.03%).
Price Target: ₹771.25 (+22.65%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NSE:NEPHROPLUS stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 2 | 2 |
| Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 4 | 4 |
Financial Forecast
Revenue This Year
11.78B
from 9.99B
Increased by 17.92%
Revenue Next Year
14.09B
from 11.78B
Increased by 19.59%
EPS This Year
16.26
from 8.10
Increased by 100.71%
EPS Next Year
20.39
from 16.26
Increased by 25.42%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.